{"id":"medication-augmentation","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Medication augmentation","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:09:27.262091+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:09:32.512317+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Medication augmentation","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:09:32.815554+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108889/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:09:33.674752+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:54:20.105Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:09:35.339638+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07472283","phase":"","title":"Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma","status":"NOT_YET_RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2026-04","conditions":"Paediatric Asthma","enrollment":42},{"nctId":"NCT07410988","phase":"PHASE4","title":"Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-04-01","conditions":"Cardiac Surgery","enrollment":1292},{"nctId":"NCT07459075","phase":"PHASE4","title":"Radiographical, Histomorphometrical and Biomarker Analysis After Maxillary Sinus Augmentation Utilizing Xenograft Particulate Bone Graft Mixed With Parathyroid Hormone","status":"RECRUITING","sponsor":"University of Baghdad","startDate":"2025-05-01","conditions":"Maxillary Sinus Augmentation","enrollment":30},{"nctId":"NCT07367698","phase":"NA","title":"Scaffold-guided Breast Implant Revision Surgery","status":"RECRUITING","sponsor":"BellaSeno Pty Ltd","startDate":"2026-02-13","conditions":"Breast Implant Revision, Breast Augmentation Complications","enrollment":73},{"nctId":"NCT07448532","phase":"NA","title":"Comparative Effects of Functional Electrical Stimulation and Mirror Therapy for Foot Clearance Among Patients With Sub-acute Stroke","status":"RECRUITING","sponsor":"Lahore University of Biological and Applied Sciences","startDate":"2026-01-22","conditions":"Stroke (Subacute)","enrollment":38},{"nctId":"NCT07139834","phase":"PHASE1","title":"Pattern Separation in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jeffrey Miller","startDate":"2026-04","conditions":"Major Depressive Disorder (MDD)","enrollment":30},{"nctId":"NCT06011551","phase":"NA","title":"HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs","status":"RECRUITING","sponsor":"ReGelTec, Inc.","startDate":"2025-01-13","conditions":"Degenerative Disc Disease (DDD)","enrollment":225},{"nctId":"NCT07367711","phase":"","title":"The Influence of Chemotherapy on Position Sense","status":"NOT_YET_RECRUITING","sponsor":"KU Leuven","startDate":"2026-02","conditions":"CIPN - Chemotherapy-Induced Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer","enrollment":145},{"nctId":"NCT06404099","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2024-08-12","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":361},{"nctId":"NCT06937476","phase":"NA","title":"Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-05-08","conditions":"Major Depressive Disorder (MDD), Rumination","enrollment":108},{"nctId":"NCT06404086","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-07-31","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":830},{"nctId":"NCT05317000","phase":"PHASE2","title":"5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC","status":"RECRUITING","sponsor":"Barbara Burtness","startDate":"2023-03-23","conditions":"Squamous Cell Carcinoma of Head and Neck","enrollment":50},{"nctId":"NCT04411225","phase":"PHASE3","title":"Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2022-06-01","conditions":"Early Psychosis","enrollment":120},{"nctId":"NCT07326124","phase":"PHASE3","title":"Stratification and Treatment in Early Psychosis Study -ASSIST","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2026-06","conditions":"Treatment Resistant Psychosis, Psychosis","enrollment":250},{"nctId":"NCT05268094","phase":"NA","title":"Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carelon Research","startDate":"2022-06-02","conditions":"Congenital Heart Disease in Children","enrollment":300},{"nctId":"NCT07237880","phase":"NA","title":"Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter","status":"RECRUITING","sponsor":"Hillel Yaffe Medical Center","startDate":"2025-04-22","conditions":"Labor, Induced","enrollment":184},{"nctId":"NCT05171686","phase":"PHASE4","title":"Diuretics and Volume Overload in Early CKD","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2023-02-01","conditions":"Chronic Kidney Disease, Hypertension","enrollment":49},{"nctId":"NCT04414930","phase":"PHASE2","title":"Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2020-11-09","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":68},{"nctId":"NCT06778564","phase":"PHASE3","title":"Stratification and Treatment in Early Psychosis Study - ENHANCE","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2026-02","conditions":"Psychosis, First Episode Psychosis, Psychotic Disorders","enrollment":250},{"nctId":"NCT03909178","phase":"NA","title":"Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2013-10-21","conditions":"Acetabular Labrum Tear, Femoro Acetabular Impingement, Hip Arthroscopy","enrollment":110},{"nctId":"NCT06049953","phase":"","title":"Maternal And Infant Antipsychotic Study","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-09-29","conditions":"Antipsychotics, Pregnancy","enrollment":200},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT06956157","phase":"PHASE4","title":"NAC for Treatment-Resistant OCD and Other Related Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2022-06-22","conditions":"Obsessive Compulsive Disorder (OCD)","enrollment":90},{"nctId":"NCT07075835","phase":"NA","title":"Enhanced External Counterpulsation for Patients With Ventilation Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-11-01","conditions":"Chronic Lung Diseases","enrollment":80},{"nctId":"NCT07088380","phase":"PHASE3","title":"Ketamine Augmentation of ECT in Treatment-Resistant Depression","status":"RECRUITING","sponsor":"Università Vita-Salute San Raffaele","startDate":"2025-07-10","conditions":"Major Depressive Disorder, Treatment Resistant Depression","enrollment":30},{"nctId":"NCT05609916","phase":"NA","title":"CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2022-11-30","conditions":"Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder, Obsessive-Compulsive Disorder in Children","enrollment":200},{"nctId":"NCT04055428","phase":"PHASE2","title":"NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2020-08-15","conditions":"Diabetes Mellitus, Cardiovascular Diseases, Insulin Sensitivity/Resistance","enrollment":200},{"nctId":"NCT07011693","phase":"PHASE4","title":"Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)","status":"NOT_YET_RECRUITING","sponsor":"Xinyu Zhou","startDate":"2025-06-20","conditions":"Major Depressive Disorder (MDD)","enrollment":400},{"nctId":"NCT04222205","phase":"NA","title":"Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2019-12-01","conditions":"Ventilator Weaning","enrollment":2143},{"nctId":"NCT06990217","phase":"PHASE4","title":"Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor","status":"NOT_YET_RECRUITING","sponsor":"HaEmek Medical Center, Israel","startDate":"2025-06","conditions":"Induction of Labor, Augmentation of Labor","enrollment":130},{"nctId":"NCT04715802","phase":"","title":"Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel","status":"ACTIVE_NOT_RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2006-10-18","conditions":"Breast, Mammaplasty, Breast Reconstruction","enrollment":240},{"nctId":"NCT02752542","phase":"PHASE4","title":"Personalized Indications for CBT and Antidepressants in Treating Depression","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2016-10-31","conditions":"Major Depressive Disorder, Persistent Depressive Disorder","enrollment":80},{"nctId":"NCT04597190","phase":"PHASE4","title":"Sequenced Treatment Effectiveness for Posttraumatic Stress","status":"COMPLETED","sponsor":"University of Washington","startDate":"2020-06-01","conditions":"PTSD","enrollment":700},{"nctId":"NCT03913819","phase":"","title":"Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2011-12-10","conditions":"Voiding Dysfunction, Substance Abuse","enrollment":1000},{"nctId":"NCT06935747","phase":"PHASE4","title":"Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)","status":"NOT_YET_RECRUITING","sponsor":"Mario Pérez Sayáns","startDate":"2025-07","conditions":"Bone Loss, Regenerative Inflammation, Third Molars Extraction","enrollment":30},{"nctId":"NCT06112990","phase":"PHASE3","title":"Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-11-09","conditions":"Metastatic Prostate Cancer","enrollment":200},{"nctId":"NCT01604512","phase":"NA","title":"A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-05","conditions":"Brain Cancer","enrollment":148},{"nctId":"NCT04581603","phase":"PHASE4","title":"CBT-I Augmentation of Medication for Drinking in AUD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2022-06-15","conditions":"Alcohol Use Disorder With Insomnia","enrollment":82},{"nctId":"NCT04421989","phase":"NA","title":"Parent Emotion Coaching for Anorexia Nervosa","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-06-24","conditions":"Anorexia Nervosa, Atypical Anorexia Nervosa","enrollment":41},{"nctId":"NCT06533397","phase":"NA","title":"The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation","status":"RECRUITING","sponsor":"Semmelweis University","startDate":"2024-08-24","conditions":"Alveolar Bone Loss, Edentulism Nos","enrollment":40},{"nctId":"NCT01041495","phase":"PHASE4","title":"Cyclobenzaprine Extended Release (ER) for Fibromyalgia","status":"TERMINATED","sponsor":"State University of New York - Upstate Medical University","startDate":"2009-06","conditions":"Fibromyalgia, Pain, Sleep","enrollment":37},{"nctId":"NCT05159713","phase":"NA","title":"Study to Compare the Use of a Behavioral Health App Versus Care As Usual for 16-22 Year Olds with Depression","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2022-06-01","conditions":"Depression","enrollment":185},{"nctId":"NCT00581009","phase":"PHASE1, PHASE2","title":"The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2001-05-30","conditions":"Major Depressive Disorder, Bipolar Disorder","enrollment":49},{"nctId":"NCT03187080","phase":"PHASE4","title":"Enhanced Recovery Strategies in Elective Breast Surgery","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2017-10-19","conditions":"Pain, Acute, Nausea, Vomiting, Postoperative","enrollment":113},{"nctId":"NCT05937243","phase":"NA","title":"Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating","status":"ACTIVE_NOT_RECRUITING","sponsor":"Drexel University","startDate":"2022-09-01","conditions":"Binge Eating, Binge-Eating Disorder, Bulimia Nervosa","enrollment":76},{"nctId":"NCT04741906","phase":"","title":"Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication","status":"RECRUITING","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2017-08-01","conditions":"Missing Teeth, Implants, Cancer","enrollment":225},{"nctId":"NCT05654220","phase":"NA","title":"Linking Emergency Department Patients to Assistance Programs Study","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2023-07-19","conditions":"Social Determinants of Health","enrollment":161},{"nctId":"NCT06467474","phase":"NA","title":"Psychoeducational Group for Depression","status":"RECRUITING","sponsor":"Ricardo Alberto Moreno, M.D., Ph.D.","startDate":"2024-03-01","conditions":"Major Depressive Disorder (MDD","enrollment":338},{"nctId":"NCT05535920","phase":"PHASE4","title":"A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia","status":"COMPLETED","sponsor":"NephroNet, Inc.","startDate":"2022-04-14","conditions":"Hyperkalemia","enrollment":88},{"nctId":"NCT05852730","phase":"PHASE2","title":"Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance","status":"RECRUITING","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2021-08-10","conditions":"Motion Sickness, Space, Motion Simulation, Parabolic Flight","enrollment":80},{"nctId":"NCT05156294","phase":"PHASE3","title":"Effect of Soft Tissue Augmentation With an Acellular Dermal Matrix in Marginal Bone Levels Around Implants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2022-01-10","conditions":"Dental Implant Failure Nos","enrollment":30},{"nctId":"NCT04307069","phase":"NA","title":"Management of Prelabor Rupture of the Membranes at Term","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2020-05-01","conditions":"Fetal Infection, Chorioamnionitis, Endometritis","enrollment":524},{"nctId":"NCT06338241","phase":"PHASE4","title":"Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model","status":"RECRUITING","sponsor":"Mario Pérez Sayáns","startDate":"2024-03-02","conditions":"Bone Loss, Regenerative Inflammation","enrollment":30},{"nctId":"NCT03932656","phase":"","title":"Latent Toxoplasmosis in Females With Borderline Personality Disorder","status":"WITHDRAWN","sponsor":"Marie Ociskova","startDate":"2021-01-01","conditions":"Borderline Personality Disorder, Toxoplasmosis","enrollment":""},{"nctId":"NCT06306209","phase":"","title":"Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2021-05-18","conditions":"Mood Disorders, Major Depressive Disorder","enrollment":80},{"nctId":"NCT06301191","phase":"","title":"The Effect of Semaglutide on Cardiovascular Markers and Liver Function","status":"RECRUITING","sponsor":"Attikon Hospital","startDate":"2022-03-01","conditions":"Diabetes Type 2","enrollment":50},{"nctId":"NCT03152409","phase":"PHASE2","title":"Salicylic Augmentation in Depression","status":"TERMINATED","sponsor":"Jessica Harder","startDate":"2018-11-15","conditions":"Depression, Depressive Disorder, Major Depressive Disorder","enrollment":32},{"nctId":"NCT04504500","phase":"NA","title":"Reducing Cesarean Section Rates and Enhancing Vaginal Delivery in Greece: a Stepped-Wedge Randomized Controlled Trial","status":"COMPLETED","sponsor":"Hellenic Society of Obstetrics and Gynecology","startDate":"2021-05-31","conditions":"Cesarean Section Rates","enrollment":6029},{"nctId":"NCT04996433","phase":"NA","title":"A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients","status":"RECRUITING","sponsor":"University of Greifswald","startDate":"2021-12-01","conditions":"Persistent Depressive Disorder, Treatment-resistant Depression","enrollment":396},{"nctId":"NCT06060119","phase":"PHASE2","title":"Comparison of Microneedling and CTG for Gingival Augmentation- A RCT","status":"UNKNOWN","sponsor":"Krishnadevaraya College of Dental Sciences & Hospital","startDate":"2023-11-28","conditions":"Gingival Phenotype","enrollment":12},{"nctId":"NCT06025474","phase":"PHASE3","title":"Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome","status":"UNKNOWN","sponsor":"Federico II University","startDate":"2023-01-01","conditions":"Burning Mouth Syndrome","enrollment":203},{"nctId":"NCT00701220","phase":"PHASE4","title":"Statin Therapy for Ischemic and Nonischemic Cardiomyopathy","status":"COMPLETED","sponsor":"Philip Binkley","startDate":"2007-04","conditions":"Cardiovascular Disease, Cardiomyopathy, Heart Disease","enrollment":9},{"nctId":"NCT04280965","phase":"EARLY_PHASE1","title":"Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2019-02-01","conditions":"Post Traumatic Stress Disorder","enrollment":28},{"nctId":"NCT03039036","phase":"NA","title":"Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2017-09-12","conditions":"Labor Induction","enrollment":69},{"nctId":"NCT02226367","phase":"NA","title":"Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD","status":"COMPLETED","sponsor":"Seattle Institute for Biomedical and Clinical Research","startDate":"2015-01","conditions":"Alcohol Use Disorders, Stress Disorders, Posttraumatic, Combat Disorders","enrollment":158},{"nctId":"NCT03653858","phase":"NA","title":"Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression","status":"UNKNOWN","sponsor":"University Hospital Freiburg","startDate":"2018-09-03","conditions":"Treatment-resistant Depression","enrollment":47},{"nctId":"NCT05537558","phase":"","title":"Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)","status":"UNKNOWN","sponsor":"University Hospital Muenster","startDate":"2021-09-09","conditions":"Major Depressive Disorder","enrollment":300},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT02973425","phase":"NA","title":"Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2016-11-07","conditions":"Smoking Cessation","enrollment":433},{"nctId":"NCT00273624","phase":"PHASE3","title":"Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial","status":"WITHDRAWN","sponsor":"University Hospital Freiburg","startDate":"2005-06","conditions":"Therapy-resistant Depression","enrollment":""},{"nctId":"NCT00276978","phase":"PHASE3","title":"Aripiprazole Augmentation Therapy in Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"University Hospital Freiburg","startDate":"2005-06","conditions":"Therapy-resistant Depression","enrollment":""},{"nctId":"NCT02922725","phase":"PHASE4","title":"Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females","status":"TERMINATED","sponsor":"Brent Michael Kious, MD, PhD","startDate":"2016-11","conditions":"Major Depressive Disorder","enrollment":32},{"nctId":"NCT01883817","phase":"PHASE3","title":"Effect of Omega-3 Fatty Acid on Cortical Function in ADHD","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2013-09","conditions":"Attention Deficit Disorder","enrollment":30},{"nctId":"NCT01665573","phase":"EARLY_PHASE1","title":"Cannabinoid Augmentation of Fear Response in Humans","status":"COMPLETED","sponsor":"Yale University","startDate":"2012-07-17","conditions":"Fear Conditioning","enrollment":31},{"nctId":"NCT04647513","phase":"NA","title":"Evaluation of the Efficacy and Safety of Three Injectable Hyaluronic Acid-based Fillers: Art Filler® Fine Lines, Art Filler® Universal and Art Filler® Lips","status":"COMPLETED","sponsor":"Laboratoires FILLMED","startDate":"2019-04-12","conditions":"Loss of Face Volume","enrollment":232},{"nctId":"NCT02642315","phase":"NA","title":"The Effect of Horizant (Gabapentin Enacarbil) on Augmentation","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2016-01","conditions":"Restless Legs Syndrome","enrollment":10},{"nctId":"NCT02487797","phase":"PHASE4","title":"Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-09-28","conditions":"Dystocia","enrollment":1003},{"nctId":"NCT03511599","phase":"PHASE1","title":"Cycloserine rTMS Plasticity Augmentation in Depression","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2018-09-03","conditions":"Major Depressive Disorder","enrollment":12},{"nctId":"NCT04192110","phase":"PHASE4","title":"Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2020-08-11","conditions":"Chronic Kidney Disease","enrollment":""},{"nctId":"NCT04496908","phase":"EARLY_PHASE1","title":"Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)","status":"COMPLETED","sponsor":"Christiana Care Health Services","startDate":"2020-09-16","conditions":"Induction of Labor Affected Fetus / Newborn","enrollment":160},{"nctId":"NCT00001005","phase":"PHASE1","title":"A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT00006495","phase":"PHASE1","title":"Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":80},{"nctId":"NCT05071573","phase":"NA","title":"Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South Africa","status":"UNKNOWN","sponsor":"University of Sussex","startDate":"2022-03","conditions":"HIV Infections","enrollment":1500},{"nctId":"NCT05015595","phase":"PHASE3","title":"Memantine for Refractory OCD Patients","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2021-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":20},{"nctId":"NCT02634684","phase":"PHASE2","title":"Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2014-07-01","conditions":"Schizophrenia","enrollment":82},{"nctId":"NCT04159285","phase":"NA","title":"Psychotherapeutic Augmentation of Brain Stimulation Effects","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2019-01-05","conditions":"Depression Chronic, Depression, Unipolar, Treatment Resistant Depression","enrollment":16},{"nctId":"NCT04971382","phase":"PHASE4","title":"Alveolar Ridge Augmentation With Curcumin Combined With Xenograft","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2021-12-01","conditions":"Horizontal Alveolar Bone Loss","enrollment":18},{"nctId":"NCT04032977","phase":"","title":"Safety and Effectiveness of PN40082 for Lip Augmentation","status":"COMPLETED","sponsor":"Prollenium Medical Technologies Inc.","startDate":"2018-07-13","conditions":"Lip Augmentation","enrollment":158},{"nctId":"NCT00905424","phase":"PHASE2","title":"Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant","status":"COMPLETED","sponsor":"Shire","startDate":"2009-07-30","conditions":"Major Depressive Disorder","enrollment":246},{"nctId":"NCT02155829","phase":"PHASE1, PHASE2","title":"Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)","status":"COMPLETED","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2013-07","conditions":"PTSD","enrollment":75},{"nctId":"NCT04162444","phase":"","title":"Results of the Aortic Valve Reconstruction in Children","status":"RECRUITING","sponsor":"National Medical Research Center for Children's Health, Russian Federation","startDate":"2020-02-18","conditions":"Aortic Valve Insufficiency","enrollment":40},{"nctId":"NCT01206608","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2008-03","conditions":"Postoperative Pain","enrollment":40},{"nctId":"NCT01066026","phase":"PHASE2","title":"Safety and Efficacy of a Metallic Cannula Versus A Standard Needle for Soft Tissue Augmentation of the Nasolabial Folds","status":"COMPLETED","sponsor":"Hexsel Dermatology Clinic","startDate":"2009-07","conditions":"Wrinkles","enrollment":25},{"nctId":"NCT00076258","phase":"NA","title":"Adding Exercise to Antidepressant Medication Treatment for Depression","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2003-04","conditions":"Depression","enrollment":126},{"nctId":"NCT04078438","phase":"NA","title":"Neurofeedback In Treatment Resistant Depression","status":"TERMINATED","sponsor":"Yeungnam University Hospital","startDate":"2014-06-27","conditions":"Depression, Neurofeedback","enrollment":70},{"nctId":"NCT00539188","phase":"PHASE2","title":"N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD","status":"TERMINATED","sponsor":"Yale University","startDate":"2007-09","conditions":"Borderline Personality Disorder, Self-Injurious Behavior","enrollment":6},{"nctId":"NCT00539513","phase":"PHASE2","title":"N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder","status":"TERMINATED","sponsor":"Yale University","startDate":"2006-06","conditions":"Obsessive-Compulsive Disorder","enrollment":10},{"nctId":"NCT00523718","phase":"PHASE2","title":"Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder","status":"COMPLETED","sponsor":"Yale University","startDate":"2006-09","conditions":"Obsessive-compulsive Disorder, Ocd","enrollment":40},{"nctId":"NCT00229450","phase":"PHASE4","title":"Estrogen and Perimenopausal Depression","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2002-04","conditions":"Depressive Disorder, Major, Menopause","enrollment":17},{"nctId":"NCT00826059","phase":"NA","title":"Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window","status":"COMPLETED","sponsor":"BrainsGate","startDate":"2011-06","conditions":"Ischemic Stroke","enrollment":1078}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2108889"},"_approvalHistory":[],"publicationCount":36,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Prazosin is the first choice agent in this Arm"],"phase":"marketed","status":"active","brandName":"Medication augmentation","genericName":"Medication augmentation","companyName":"Massachusetts General Hospital","companyId":"massachusetts-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:09:35.339638+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}